Eastman Chemical stock kpis
Want to see EMN full AI Analyst Report?
Adjusted EBIT by Segment
Eastman Chemical reported adjusted EBIT by segment of $305.00M in Q3 2026, down 4.7% from Q2 2026 and up 45.2% year over year. The highest value was $469.00M in Q2 2022.
Shows earnings before interest and taxes for each segment, adjusted for one-time items, providing insight into core profitability and operational efficiency.
Additives & Functional Products has become Eastman’s most reliable earnings driver, providing steady upward momentum, while Fibers has rolled over from its 2023 highs and is a weakening contributor to margins. Chemical Intermediates shows extreme cyclicality—deep losses through 2025 but a sharp rebound in the most recent quarter, suggesting a commodity-price or operational reset rather than secular improvement. The persistent, large negative 'Other' line (corporate/unallocated items) is the primary drag on consolidated adjusted EBIT and the biggest execution risk to watch.
EMN Adjusted EBIT by Segment
| Period | Advanced Materials | Additives and Functional Products | Chemical Intermediates | Fibers | Other | Total |
|---|---|---|---|---|---|---|
| Q3 2026Sep 30, 2026 | $103.00M | $154.00M | $35.00M | $52.00M | -$39.00M | $305.00M |
| Q2 2026Jun 30, 2026 | $109.00M | $151.00M | $58.00M | $36.00M | -$34.00M | $320.00M |
| Q1 2026Mar 31, 2026 | $69.00M | $142.00M | -$18.00M | $45.00M | -$38.00M | $200.00M |
| Q4 2025Dec 31, 2025 | $59.00M | $94.00M | -$28.00M | $49.00M | -$40.00M | $134.00M |
| Q3 2025Sep 30, 2025 | $53.00M | $128.00M | $1.00M | $67.00M | -$39.00M | $210.00M |
| Q2 2025Jun 30, 2025 | $121.00M | $153.00M | -$30.00M | $81.00M | -$50.00M | $275.00M |
| Q1 2025Mar 31, 2025 | $116.00M | $137.00M | $19.00M | $88.00M | -$53.00M | $307.00M |
| Q4 2024Dec 31, 2024 | $107.00M | $128.00M | $20.00M | $103.00M | -$53.00M | $305.00M |
| Q3 2024Sep 30, 2024 | $122.00M | $130.00M | $43.00M | $112.00M | -$41.00M | $366.00M |
| Q2 2024Jun 30, 2024 | $131.00M | $123.00M | $22.00M | $122.00M | -$45.00M | $353.00M |
| Q1 2024Mar 31, 2024 | $104.00M | $109.00M | $16.00M | $117.00M | -$72.00M | $274.00M |
| Q4 2023Dec 31, 2023 | $65.00M | $67.00M | $24.00M | $113.00M | -$47.00M | $222.00M |
| Q3 2023Sep 30, 2023 | $93.00M | $105.00M | $6.00M | $109.00M | -$57.00M | $256.00M |
| Q2 2023Jun 30, 2023 | $99.00M | $140.00M | $39.00M | $106.00M | -$48.00M | $336.00M |
| Q1 2023Mar 31, 2023 | $86.00M | $124.00M | $42.00M | $94.00M | -$63.00M | $283.00M |
| Q4 2022Dec 31, 2022 | $43.00M | $76.00M | $24.00M | $58.00M | -$30.00M | $171.00M |
| Q3 2022Sep 30, 2022 | $132.00M | $126.00M | $86.00M | $21.00M | -$32.00M | $333.00M |
| Q2 2022Jun 30, 2022 | $158.00M | $148.00M | $155.00M | $37.00M | -$29.00M | $469.00M |
| Q1 2022Mar 31, 2022 | $62.00M | $167.00M | $113.00M | $24.00M | $0.00 | $366.00M |
| Q4 2021Dec 31, 2021 | $100.00M | $107.00M | $112.00M | $28.00M | -$11.00M | $336.00M |
| Q3 2021Sep 30, 2021 | $128.00M | $131.00M | $132.00M | $32.00M | $22.00M | $445.00M |
| Q2 2021Jun 30, 2021 | $153.00M | $111.00M | $144.00M | $37.00M | $9.00M | $454.00M |
| Q1 2021Mar 31, 2021 | $151.00M | $137.00M | $73.00M | $45.00M | -$6.00M | $400.00M |
| Q4 2020Dec 31, 2020 | $138.00M | $118.00M | $36.00M | $40.00M | -$3.00M | $329.00M |
| Q3 2020Sep 30, 2020 | $139.00M | $109.00M | $32.00M | $41.00M | -$11.00M | $310.00M |
| Q2 2020Jun 30, 2020 | $64.00M | $72.00M | $22.00M | $46.00M | -$9.00M | $195.00M |
| Q1 2020Mar 31, 2020 | $107.00M | $149.00M | $81.00M | $53.00M | -$8.00M | $382.00M |
| Q4 2019Dec 31, 2019 | $112.00M | $109.00M | $22.00M | $50.00M | -$14.00M | $279.00M |
| Q3 2019Sep 30, 2019 | $159.00M | $144.00M | $34.00M | $51.00M | -$19.00M | $369.00M |
| Q2 2019Jun 30, 2019 | $145.00M | $147.00M | $63.00M | $51.00M | -$17.00M | $389.00M |
| Q1 2019Mar 31, 2019 | $102.00M | $150.00M | $73.00M | $42.00M | -$15.00M | $352.00M |

